EcoDrugPlus

Adam Metallopeptidase Domain 17a

Ensembl ID : ENSSSAG00000044555
Gene Symbol: ADAM17A
3 Cross references
201 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSSSAG00000112181
Gene Symbol: ADAMTS5
5 Cross references
193 Possible Orthologues:

Alk Receptor Tyrosine Kinase

Ensembl ID : ENSSSAG00000111056
Gene Symbol: ALK
2 Cross references
185 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSSSAG00000096370
Gene Symbol: APEX1
3 Cross references
208 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSSSAG00000006675
Gene Symbol: APEX1
4 Cross references
205 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSSSAG00000046932
Gene Symbol: ABCB1
4 Cross references
163 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSSSAG00000110237
Gene Symbol: ABCB1
2 Cross references
163 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSSSAG00000115945
Gene Symbol: ABCC1
4 Cross references
197 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSSSAG00000094035
Gene Symbol: ABCC1
2 Cross references
197 Possible Orthologues:

Atp-Binding Cassette Sub-Family C Member 8

Ensembl ID : ENSSSAG00000079354
Gene Symbol: LOC106584588
4 Cross references
223 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSSSAG00000063140
Gene Symbol: ABCC8
2 Cross references
223 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSSSAG00000008459
Gene Symbol: ABCC9
2 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).